Sign in

Steven Orlando

Director at MOLINA HEALTHCARE
Board

About Steven J. Orlando

Independent director with over 40 years in corporate finance and accounting; founder of Orlando Company (financial management and business consulting) since 2000; former CFO across multiple companies (1978–2000) and CPA at Coopers & Lybrand (1974–1977). Age 73; director since 2005; B.S. in Accounting (California State University, Sacramento); CPA (inactive). Current committee roles: Audit (Chair & Financial Expert), Corporate Governance & Nominating, and Finance .

Past Roles

OrganizationRoleTenureCommittees/Impact
Orlando CompanyFounder2000–presentFinancial management and business consulting practice
Various companiesChief Financial Officer1978–2000Corporate finance leadership
Coopers & Lybrand CPAsCertified Public Accountant1974–1977Audit experience and accounting rigor

External Roles

OrganizationRoleTenureCommittees/Impact
Greater Sacramento BancorpDirector; Audit Committee ChairJan 2009–Jan 2015Audit leadership
Pacific Crest Capital, Inc. (Nasdaq-listed)Audit Committee Chair1995–2004Public company audit oversight

Board Governance

TopicDetails
Committee assignmentsAudit (Chair; financial expert), Corporate Governance & Nominating (member), Finance (member)
IndependenceAll directors except CEO are independent; Audit Committee members are independent under NYSE rules; Orlando qualifies as an “audit committee financial expert”
Meetings (2024)Board 10; Audit 9; Corporate Governance & Nominating 3; Compensation 7; Compliance & Quality 3; Finance 8
AttendanceEach current director attended at least 75% of Board and applicable committee meetings; all directors attended the May 1, 2024 annual meeting
Executive sessionsIndependent directors customarily meet in executive session at each in-person regular Board meeting (usually four per year)
Risk oversightAudit oversees enterprise risk management, cybersecurity/data security, financial risk; Corporate Governance oversees independence and conflicts, related person transactions; Finance oversees capital structure, credit, liquidity, operations

Fixed Compensation

ComponentAmountNotes
Annual cash retainer (non-employee directors)$125,000Standard cash retainer
Audit Committee Chair fee$32,500Additional annual cash fee
Corporate Governance & Nominating Committee member fee$12,500Additional annual cash fee
Finance Committee member fee$15,000Additional annual cash fee
Per diem (non-ordinary course activity)$1,000For non-ordinary Board/committee activity; excludes educational events
Orlando—Fees earned (2024)$185,000Sum aligns with retainer + committee roles above

Performance Compensation

ComponentValue/TermsVesting/Metrics
Annual director equity award (RS)$220,000 total; $55,000 per quarterGranted first day of each quarter; vests immediately; based on closing price; no performance metrics disclosed
Orlando—Stock awards (2024, grant date fair value)$219,864Aggregated fair value of four RS grants
2024 grant dates and closing prices (used for share calc)Jan 1: $361.31; Apr 1: $404.20; Jul 1: $292.16; Oct 1: $341.91Number of shares derived from these prices; awards may be rounded for fractional shares
Options/unvested stock (as of 12/31/2024)NoneNo stock options or unvested stock awards held by non-employee directors
Plan limits/dividends (2025 Plan)Non-employee director comp cap $750,000 (cash + grant-date FV of awards); dividend equivalents on full-value awards vest only if the underlying award vests

Other Directorships & Interlocks

CompanyRolePotential Interlock/Notes
Greater Sacramento BancorpDirector; Audit Chair (2009–2015)Prior public company board; audit oversight experience
Pacific Crest Capital, Inc.Audit Chair (1995–2004)Prior Nasdaq-listed company; audit oversight experience

Expertise & Qualifications

  • Extensive corporate finance and accounting background; former CFO across multiple companies .
  • CPA (inactive) and chair of Audit Committee; designated audit committee financial expert .
  • Governance experience across multiple boards; member of Corporate Governance & Nominating and Finance Committees .
  • Long-standing board tenure provides historical context and continuity .

Equity Ownership

HolderShares Beneficially OwnedPercent of OutstandingComposition/Notes
Steven J. Orlando18,875<1%17,375 shares via Orlando Family Trust; 1,500 shares via 401(k) plan
Shares outstanding (as of 3/7/2025)54,699,859Company total shares used for percentage computation
Ownership guidelines (directors)≥5x annual cash retainerCompliance statusAll non-employee directors met guidelines as of 12/31/2024; retention of 50% net-settled shares until compliant
Hedging/pledging policyProhibited for directors and executivesInsider trading policy prohibits short sales, hedging, and pledging

Insider Trades (Form 4)

Filing DateTransaction DateTypeSharesPricePost-Transaction HoldingsOwnership TypeSEC Link
2025-10-022025-10-01A (Award)285$192.7917,008Indirecthttps://www.sec.gov/Archives/edgar/data/1179929/000121149325000003/0001211493-25-000003-index.htm
2025-07-022025-07-01A (Award)180$306.2916,723Indirecthttps://www.sec.gov/Archives/edgar/data/1179929/000117992925000108/0001179929-25-000108-index.htm
Data source: Insider-trades skill; records reflect RS awards consistent with quarterly director equity grants.

Governance Assessment

  • Board effectiveness: As Audit Committee Chair and financial expert, Orlando led the committee’s 2024 oversight, including recommending inclusion of audited financials in the 2024 Form 10-K; the committee met separately with internal and independent auditors and affirmed auditor independence . Independence standards confirmed for Audit Committee members; broader Board independence disclosed (all except CEO) .
  • Attendance & engagement: Board and committee cadence is robust (Board 10; Audit 9; Finance 8; CG&N 3 in 2024); all directors achieved at least 75% attendance and attended the 2024 annual meeting—supports engagement .
  • Compensation alignment: Director pay mix balances cash ($185k for Orlando in 2024) and equity (~$220k RS annually, immediate vest) with a non-employee director cap ($750k) under the 2025 plan; no options or performance-linked metrics for directors, which is typical but reduces direct pay-for-performance linkage for directors .
  • Ownership alignment: Orlando’s beneficial ownership (18,875 shares) and Board-wide compliance with stringent stock ownership guidelines (≥5x cash retainer) bolster alignment; policy bans hedging and pledging, mitigating misalignment risks .
  • Conflicts/related-party exposure: Corporate Governance & Nominating oversees conflicts and related party transactions; no related-person transactions involving Orlando disclosed; one related-person transaction (employment of a director’s family member) was reviewed and ratified under policy .
  • Refreshment/tenure: Orlando’s long tenure (since 2005) provides continuity; Board instituted 12-year term limits for independent directors first elected beginning in 2020 and engaged a third-party search firm in 2024 to add new talent—mitigates staleness risk while preserving experience .

RED FLAGS: None disclosed specific to Orlando. No pledging/hedging, no related-party transactions, and attendance threshold met . Potential watchpoint: long tenure versus evolving best practices, offset by active Board refresh processes .

Best AI for Equity Research

Performance on expert-authored financial analysis tasks

Fintool-v490%
Claude Sonnet 4.555.3%
o348.3%
GPT 546.9%
Grok 440.3%
Qwen 3 Max32.7%

Best AI for Equity Research

Performance on expert-authored financial analysis tasks

Fintool-v490%
Claude Sonnet 4.555.3%
o348.3%
GPT 546.9%
Grok 440.3%
Qwen 3 Max32.7%